Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

71 Citation Laureates named by the Institute for Scientific Information have gone on to receive a Nobel Prize LONDON , Sept. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today named 23 world-class researchers from institutions in five countries as Citation Laureates™.

Clarivate Unveils Citation Laureates 2023 - Annual List of Researchers of Nobel Class

LONDON , Sept. 18, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that its Board of Directors unanimously approved the termination of the Company's tax benefits preservation plan (the "Tax Benefits Preservation Plan"), which was originally put in place in December 2022 and was set to expire October 31, 2023, was designed to protect the availability of Clarivate's U.S. net operating loss carryforwards and certain other U.S. tax attributes.

Clarivate Announces Termination of Tax Benefits Preservation Plan

New dynamic, interactive data visualizations illuminate shifts in global research landscape and enable rapid comparative analyses LONDON , Aug. 30, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its annual G20 scorecard, which for the first time examines the research performance of each G20 member through dynamic, interactive data visualizations. It offers a detailed and insightful overview of research trends, collaboration patterns and scientific impact, showcasing the contributions of the 19 G20 member nations* to the global research landscape.

Clarivate Annual G20 Scorecard Analyzes Global Research Performance Trends Across G20 Nations

LONDON , Aug. 24, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Goldman Sachs Communacopia + Technology Conference on Thursday, September 7, 2023 at 1:45 pm Pacific Time (4:45 pm Eastern Time). The live webcast can be accessed at https://event.webcasts.com/starthere.jsp?ei=1631055&tp_key=f5079926d3&tp_special=8 and will be available for replay.

Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 7, 2023

Bi-annual trend analysis of payers and government agencies shows significant growth and disruption for insurance exchange market across multiple states LONDON , Aug. 17, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released findings from its bi-annual Managed Market Surveyor™ (MMS) health plan enrollment trend analysis. Medicaid enrollment peaked with an increase of nearly 4 million beneficiaries in the six months leading up to January 2023, but with the rollback of expansion policies under Covid, a downward shift in enrollment for the rest of this year is anticipated.

New Clarivate Trends Data Shows California, New York, Texas, and Illinois Experiencing Largest Medicaid Growth

The cloud-based SaaS has demonstrated successes with complex consortial systems and will achieve OhioLINK's user-centered vision LONDON , Aug. 16, 2023 /PRNewswire/ -- OhioLINK, Ohio's academic library consortium, announces the selection of Ex Libris Alma, part of Clarivate™ (NYSE: CLVT), as the consortium's next shared library services platform. The new cloud-based platform will enhance library user experiences and services, improve efficiencies for day-to-day operations, and streamline collaboration and consortial functionality.

OhioLINK selects Ex Libris Alma and Primo as next library services platform

Latest iteration of patent pending platform enables life sciences and pharmaceutical companies to access insights from billions of proprietary data points LONDON , Aug. 9, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today launched its new enhanced search platform leveraging generative artificial intelligence (GenAI). GenAI has the potential to yield efficiencies across the entire Life Sciences & Healthcare value chain.

Clarivate Launches Enhanced Search Powered by Generative Artificial Intelligence

Clarivate Plc (NYSE:CLVT ) Q2 2023 Earnings Conference Call August 3, 2023 9:00 AM ET Company Participants Mark Donohue - Vice President, Investor Relations Jonathan Gear - Chief Executive Officer Jonathan Collins - Executive Vice President and Chief Financial Officer Conference Call Participants Manav Patnaik - Barclays Toni Kaplan - Morgan Stanley Ashish Sabadra - RBC Capital Markets Andrew Nicholas - William Blair Hans Hoffman - Jefferies Owen Lau - Oppenheimer Seth Weber - Wells Fargo Peter Christiansen - Citi George Tong - Goldman Sachs Operator Hello, everyone, and welcome to the Clarivate Second Quarter 2023 Earnings Conference Call. My name is Nadia, and I'll be coordinating the call today.

Clarivate Plc (CLVT) Q2 2023 Earnings Call Transcript

Although the revenue and EPS for Clarivate PLC (CLVT) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Clarivate PLC (CLVT) Reports Q2 Earnings: What Key Metrics Have to Say

Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.

Clarivate PLC (CLVT) Q2 Earnings Top Estimates

LONDON , Aug. 3, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that Jonathan Gear, Chief Executive Officer, and Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at Oppenheimer's 26th Annual Technology, Internet & Communications Conference on Tuesday, August 8, 2023 at 2:05 pm Eastern Time. The live webcast can be accessed at https://wsw.com/webcast/oppenheimer30/clvt/2796615 and will be available for replay.

Clarivate to Present at Oppenheimer's 26th Annual Technology, Internet & Communications Conference on August 8

— Updates 2023 Outlook — LONDON , Aug. 3, 2023 /PRNewswire/ -- Clarivate Plc - (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust, today reported results for the second quarter. Second Quarter 2023 Financial Highlights Revenues of $668.8 million decreased 2.6%, and 3.5% at constant currency(1), driven primarily by the divestiture of MarkMonitor in October 2022, for which there were no comparable amounts in the current year period Organic revenues(1) decreased 0.4% as an increase in subscription revenues of 2.9% was offset by a decline in re-occurring revenues of 1.6% and transactional and other revenues of 7.5% Net loss attributable to ordinary shares of $141.7 million increased $185.4 million driven primarily by the impairment charge in the current year period; Net loss per diluted share of $0.21 decreased by $0.21 Adjusted Net Income(1) of $152.2 million decreased 7.8%; Adjusted Income per diluted share(1) of $0.21 decreased 4.5% or $0.01 Adjusted EBITDA(1) of $284.9 million increased 3.8% driven by cost savings from integration programs; Adjusted EBITDA Margin(1) of 42.6% increased 270 basis points Net cash provided by operating activities increased $65.2 million to $162.4 million; Free cash flow(1) increased $55.3 million to $104.8 million, allowing for continued deleveraging through further debt reduction and share repurchases  First Half of 2023 Financial Highlights Revenues of $1,297.9 million decreased 3.8%, and 3.3% at constant currency(1), driven primarily by the divestiture of MarkMonitor in October 2022, for which there were no comparable amounts in the current year period Organic revenues(1) decreased 0.3% as an increase in subscription revenues of 2.9% was offset by a decline in re-occurring revenues of 1.7% and transactional and other revenues of 7.9% Net loss attributable to ordinary shares of $117.0 million decreased $211.5 million driven primarily by the impairment charge in the current year period and lower mark-to-market gain on financial instruments; Net loss per diluted share of $0.17 decreased by $0.10 Adjusted Net Income(1) of $283.1 million decreased 11.6%; Adjusted Income per diluted share(1) of $0.39 decreased 9.3% or $0.04 Adjusted EBITDA(1) of $537.6 million increased 0.2% driven by cost savings from integration programs; Adjusted EBITDA Margin(1) of 41.4% increased 160 basis points Net cash provided by operating activities increased $225.3 million to $389.9 million; Free cash flow(1) increased $197.5 million to $273.0 million  "Clarivate continued to deliver on operational progress during the quarter, reinforcing the value proposition of our mission critical solutions across key sectors.

Clarivate Reports Second Quarter 2023 Results

New data captures German prescribing insights providing researchers with aggregated, anonymised specialty prescribing habits across brands and diseases LONDON , July 27, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the release of German hospital prescribing insights within Clarivate Patient Data Intelligence (CPDI). The introduction of the new aggregated, anonymised data product will allow for increased understanding of treatments prescribed and administered in German hospitals, providing clarity on market trends, patient characteristics, and specialty prescribing habits across brands and diseases.

Clarivate Enhances Patient Data Intelligence Solution with Addition of German Hospital Prescribing Insights

Identifies 36 companies and organizations on the cusp of Top 100 Global Innovators status LONDON, July 25, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its Innovators to watch list – 36 companies and organizations that are on the cusp of Top 100 Global Innovator™  status. Drawing on proprietary data and expertise from Clarivate™, the annual list identifies the organizations that demonstrate exceptional potential and consistent, above-the-bar innovation excellence to make them future pioneers at the forefront of innovation.

Clarivate Releases Innovators to Watch 2023 Report

Suite of news services receives four 2023 APEX Awards for Publications Excellence    LONDON , July 19, 2023 /PRNewswire/ -- BioWorld™ published by  Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, is the winner in four 2023 APEX Awards for Publication Excellence categories including: Public Health Concerns, Publication Excellence in the Design & Illustration, Publication Excellence in the Newsletters and Publication Excellence of Website. Now in its 35th year, the 2023 APEX Awards for Publication Excellence recognizes the outstanding works of professional communicators who demonstrate excellence in graphic design, editorial content, and the ability to achieve overall communications excellence.

BioWorld by Clarivate Recognized for Excellence in Publishing

Discovery and access to >5.5 million global dissertations and theses to make research more efficient    LONDON , July 13, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the integration of ProQuest™ Dissertations & Theses Global with its renowned Web of Science™ platform. This integration enables researchers to gain quick and easy access to a vast multidisciplinary collection of early career scholarship of more than 5.5 million global dissertations and theses.

Clarivate Enriches Web of Science Platform with Integration of ProQuest Dissertations and Theses Global

LONDON , July 7, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today it will report its financial results for the second quarter 2023 before the market opens on Thursday, August 3. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website.

Clarivate to Report Second Quarter 2023 Results on August 3, 2023

Clarivate is on track to meet or exceed its FY23 organic growth target of 2.75-3.75%, thanks to stronger subscription growth and easier year-over-year comparisons. The company's upgrades to the Web of Science product and incorporation of generative AI present additional growth opportunities and potential for higher structural margins. Achieving the FY25 targets will be the next key catalyst for stock valuation rerating.

Clarivate: Business On Track To Hit Mid-Single Digits Organic Growth

From ESPN to Yuga Labs – Software, media, fintech and finance and electronics brands comprise nearly one third of the list LONDON , June 29, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released the annual Top 100 New Brands report. The report draws on global trademark data covering 145 million individual trademark records, analyzing applications filed worldwide between 2021 and 2022 to identify new brands which have surged into the public sphere and demonstrated the greatest diligence in protecting and expanding their brand footprint.

Clarivate Top 100 New Brands Report Reveals Mainland China and United States Are Epicenters of Brand Creation

Reports reveal insights into the world's leading journals - more than 9,000 quality journals from more than 3,000 publishers receive a Journal Impact Factor for the first time LONDON , June 28, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released the 2023 update to its annual Journal Citation Reports™ (JCR)™. This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines.

Clarivate Unveils Journal Citation Reports 2023 - a Trusted Resource to Support Research Integrity and Promote Accurate Journal Evaluation

F5 Networks

Investors with an interest in Internet - Software stocks have likely encountered both Clarivate PLC (CLVT) and F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now?

CLVT or FFIV: Which Is the Better Value Stock Right Now?

Embedding generative AI to enable market-leading academic conversational discovery LONDON , June 22, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced a strategic partnership with AI21 Labs , a pioneer in generative artificial intelligence (AI). The collaboration will integrate large language models into solutions from Clarivate, to enable intuitive academic conversational search and discovery, specifically designed to foster researcher excellence and drive success for researchers and students, while adhering to core academic principles and values.

Clarivate Announces Partnership with AI21 Labs as part of its Generative AI Strategy to Drive Growth

Institute for Scientific Information illustrates how visualizations of publication and citation data 'unpack' information overlooked with focus on simple metrics alone LONDON , June 21, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released a report from the Institute for Scientific Information (ISI)™ which further promotes the shift from a reliance on simplistic research metrics towards an adoption of visually informative profiles. The report also encourages actionable engagement and input from the global research community.

Clarivate Report Urges Shift from Single Metrics to Visual Research Profiles

Clorox

SPX Technologies

TRI Pointe Group

Wingstop

These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Clorox (CLX), Wingstop (WING), Tri Pointe Homes (TPH), Clarivate (CLVT) and SPX Technologies Inc. (SPXC) for gains.

Invest in 5 Top Stocks Set to Exceed Earnings Estimates

The average of price targets set by Wall Street analysts indicates a potential upside of 54.5% in Clarivate PLC (CLVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

News for Clarivate Plc Stock (CLVT)